For its third fiscal quarter (ending September 30), Utah Medical Products Inc (NASDAQ: UTMD) has reported a -5% decline in E.P.S. from $1.08 a year ago to $1.03 in the current quarter. For the latest four quarters through September 30, E.P.S. were $4.28 compared to $4.65 a year ago — a decline of -8%.
Recent Price Action
Utah Medical Products Inc (NASDAQ: UTMD) stock declined slightly by -0.1% on 10/29/24. The stock closed at $64.15. However, unusually low trading volume at 58% of normal accompanied the decline. The stock has been weak relative to the market over the last nine months and has declined -2.5% during the last week.
Current PriceTarget Research Rating
UTMD is expected to continue to be a Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Utah Medical Products has a current Value Trend Rating of D (Negative). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Utah Medical Products has a neutral Appreciation Score of 42 and a slightly negative Power Rating of 31, and the Negative Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment